Background Ketamine infusions have been used for decades to treat acute pain, but a recent surge in usage has made the infusions a mainstay of treatment in emergency departments, in the perioperative period in individuals with refractory pain, and in opioid-tolerant patients. The widespread variability in patient selection, treatment parameters, and monitoring indicates a need for the creation of consensus guidelines. Methods The development of acute pain ketamine guidelines grew as a corollary from the genesis of chronic pain ketamine guidelines. The charge for the development of acute pain ketamine guidelines was provided by the Boards of Directors of both the American Society of Regional Anesthesia and Pain Medicine and the American Academy of Pain Medicine, who approved the document along with the American Society of Anesthesiologists' Committees on Pain Medicine and Standards and Practice Parameters. The committee chair developed questions based on input from the committee during conference calls, which the committee then refined. Groups of 3 to 5 panel members and the committee chair were responsible for answering individual questions. After preliminary consensus was achieved, the entire committee made further revisions via e-mail and conference calls. Results Consensus guidelines were prepared in the following areas: indications, contraindications for acute pain and whether they differ from those for chronic pain, the evidence for the use of ketamine as an adjunct to opioid-based therapy, the evidence supporting patient-controlled ketamine analgesia, the use of nonparenteral forms of ketamine, and the subanesthetic dosage range and whether the evidence supports those dosages for acute pain. The group was able to reach consensus on the answers to all questions. Conclusions Evidence supports the use of ketamine for acute pain in a variety of contexts, including as a stand-alone treatment, as an adjunct to opioids, and, to a lesser extent, as an intranasal formulation. Contraindications for acute pain are similar to those for chronic pain, partly based on the observation that the dosage ranges are similar. Larger studies evaluating different acute pain conditions are needed to enhance patient selection, determine the effectiveness of nonparenteral ketamine alternatives, define optimal treatment parameters, and develop protocols optimizing safety and access to care. Accepted for publication March 7, 2018. Address correspondence to: Steven P. Cohen, MD, 550 N Broadway, Suite 301, Baltimore, MD 21029 (e-mail: scohen40@jhmi.edu). S.P.C. is funded in part by a Congressional grant from the Center for Rehabilitation Sciences Research, Uniformed Services University of the Health Sciences, Bethesda, MD (SAP grant 111726). The authors declare no conflict of interest. The opinions or assertions contained herein are those of the authors, the American Society of Regional Anesthesia and Pain Medicine, and the American Academy of Pain Medicine and do not necessarily reflect the views of the Department of the Army or the Department of Defense. Because this document has neither been presented to nor approved by either the ASA Board of Directors or House of Delegates, it is not an official or approved statement or policy of the Society. Variances from the recommendations contained in the document may be acceptable based on the judgment of the responsible anesthesiologist. Copyright © 2018 by American Society of Regional Anesthesia and Pain Medicine.
https://ift.tt/2Jt3VUJ
Αρχειοθήκη ιστολογίου
-
►
2023
(256)
- ► Φεβρουαρίου (140)
- ► Ιανουαρίου (116)
-
►
2022
(1695)
- ► Δεκεμβρίου (78)
- ► Σεπτεμβρίου (142)
- ► Φεβρουαρίου (155)
-
►
2021
(5507)
- ► Δεκεμβρίου (139)
- ► Σεπτεμβρίου (333)
- ► Φεβρουαρίου (628)
-
►
2020
(1810)
- ► Δεκεμβρίου (544)
- ► Σεπτεμβρίου (32)
- ► Φεβρουαρίου (28)
-
►
2019
(7684)
- ► Δεκεμβρίου (18)
- ► Σεπτεμβρίου (53)
- ► Φεβρουαρίου (2841)
- ► Ιανουαρίου (2803)
-
▼
2018
(31838)
- ► Δεκεμβρίου (2810)
- ► Σεπτεμβρίου (2870)
-
▼
Ιουνίου
(2453)
-
▼
Ιουν 05
(42)
- Perioperative management of patients with cancer p...
- Olfactory bulbus volume and olfactory sulcus depth...
- Assessment modalities of non-ionizing three-dimens...
- Miriam’s Journey to Sound
- Save the Date: Dr. Steven Zeitels to Speak at ORL ...
- Amber Luong, MD, PhD Recognized as Trailblazer
- A Novel Missense Mutation in SLC5A5 Gene in a Suda...
- Dendritic cells in inflammatory angiogenesis and l...
- ECT: a new look at an old friend
- Do we really need an anesthesiologist for routine ...
- Manejo de los carcinomas diferenciados de tiroides
- La audición en la enfermedad ósea de Paget
- Olfactory dysfunction out of season in seasonal al...
- Novel Approaches to Block Complement
- Could Less Be More in Febrile Neutropenia, Too?
- Pain, psychiatric comorbidities, and psychosocial ...
- Assessment modalities of non-ionizing three-dimens...
- Consensus Guidelines on the Use of Intravenous Ket...
- Consensus Guidelines on the Use of Intravenous Ket...
- Widening of posterior glottis through rotation of ...
- Morphology and cochlear implantation in enlarged v...
- Monoclonal antibodies for the treatment of atopic ...
- Hypersensitivity reactions to beta-lactams in chil...
- Does evidence support the use of cat allergen immu...
- Needle Biopsy of Routine Thyroid Nodules Should Be...
- Scleromalacia perforans: a case report
- Longitudinal studies of the 18 F-FDG kinetics afte...
- Obturation quality of calcium silicate-based cemen...
- Increased anti- EBV VCA IgG antibody levels are as...
- Clinical outcomes following Cochlear™ BIA300 bone ...
- Improving universal newborn hearing screening outc...
- Unusual cause of obstructive uropathy: bilateral s...
- Unusual case of hypocalcaemia
- Severe bone marrow suppression due to methotrexate...
- ALL relapse with multiple cranial nerve palsies an...
- Differential diagnosis for chronic hypokalaemia
- Gitelman syndrome and primary hyperparathyroidism:...
- Serious life-threatening multifocal infection in a...
- Aspiration and altered airway anatomy: a presentat...
- Rapidly involuting congenital haemangioma of the l...
- Laryngeal Basaloid Squamous Cell Carcinoma with a ...
- Quality Of Care In Dental Institutes
-
▼
Ιουν 05
(42)
- ► Φεβρουαρίου (2420)
- ► Ιανουαρίου (2395)
-
►
2017
(31987)
- ► Δεκεμβρίου (2460)
- ► Σεπτεμβρίου (2605)
- ► Φεβρουαρίου (2785)
- ► Ιανουαρίου (2830)
-
►
2016
(5308)
- ► Δεκεμβρίου (2118)
- ► Σεπτεμβρίου (877)
- ► Φεβρουαρίου (41)
- ► Ιανουαρίου (39)
Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου